CHIROPRACTIC CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Verity Spine & Motion (name chosen to convey trust and movement) launches in 2026 as a modern outpatient clinic in the musculoskeletal healthcare sector. We deliver expert, non-invasive care combining chiropractic care, physiotherapy, and massage therapy. Our services include hands-on spinal manipulation, targeted therapeutic exercise programs, soft-tissue treatment, and evidence-based diagnostic assessments supported by $99,000 in state-of-the-art diagnostic and treatment technology. We operate a patient-centric scheduling model that guarantees predictable availability and measurable clinical outcomes. One clear goal: open in Q2 2026 and reach 1,200 patient visits in year one. One-line: We treat pain so people move and work better, faster.

Day-to-day we assess, treat, and track recovery through intake exams, individualized care plans, weekly follow-ups, and outcome reporting. We compete on faster access, integrated care pathways, and superior clinical tracking—reducing redundant referrals and improving return-to-function rates. Target patients are adults 25–65 with acute and chronic musculoskeletal pain, active workers, and recreational athletes in the metro area. Short-term goals: achieve operational break-even within 12 months and a 65% gross margin on billable services. Long-term goals: scale to three locations, staff 24 clinicians/support staff, and serve ~10,000 visits annually by year five. One-line: Scale care that’s reliable, measurable, and focused on function.

Problem

Millions of Americans live with chronic back and neck pain that reduces productivity and quality of life, yet consistent, evidence-based conservative care remains limited.

Sedentary office work and athletic demands create persistent musculoskeletal dysfunction. Existing options rely heavily on drugs or surgery, and current conservative providers rarely combine clinical depth with predictable availability and modern operational efficiency. This leaves patients facing higher out-of-pocket costs, delayed effective care, and increased risk of chronic disability and comorbidity.

There is a clear market gap for a multidisciplinary, patient-centric clinic that delivers non-invasive musculoskeletal care with reliable access and measurable outcomes.

Solution

Millions of Americans suffer chronic musculoskeletal pain and are increasingly dissatisfied with drug-heavy or invasive care; office workers and athletes lack access to structured, evidence-based manual therapy, and current clinics often fail to deliver timely, consistent appointments. One-line: we provide a practical, patient-focused alternative to pills and surgery.

Licensed professional chiropractic care delivered in a multidisciplinary model—chiropractic, physiotherapy, and therapeutic massage—focused on diagnosing root causes and restoring joint function. The clinic launches in 2026 with a target of 150 monthly treatments per chiropractor, offering comprehensive evaluations, personalized spinal adjustments, manual therapies, and coordinated long-term care plans to improve mobility and reduce relapse.

Mission Statement

Our mission is to provide the highest-quality non-invasive musculoskeletal care through a modern, patient-centric model that restores mobility and improves quality of life for our community. We commit to evidence-based practices, operational excellence, and consistent, focused treatment so every patient receives personalized care and education. We aim to be the premier U.S. destination for holistic pain management and long-term wellness, empowering patients to achieve optimal health.

Key Success Factors

Critical operational and financial targets that must be met to reach profitability and scale.

• Practitioner utilization: maintain 60% initially and reach 80% by 2030.
• Patient acquisition cost: reduce from 8% to 6% of revenue over five years.
• Talent recruitment: hire and retain licensed clinicians, including a lead chiropractor at $120,000.
• Breakeven timing: achieve cash-flow breakeven by January 2028.
• Clinical outcomes & referrals: deliver superior outcomes to drive referrals and reach Year 5 EBITDA of $1,350,000.

Financial Summary

Financial snapshot for the clinic: launch 2026, breakeven in Jan-28, and positive EBITDA by Year 3.

Financial requirements: total capital investment $99,000; maintain minimum cash position $629,000 (expected Jan‑2028). Anticipated returns: project IRR 4% and ROE 2.04.

Overall outlook: modest early losses, profitable by Year 3, and runway to positive cash by Jan‑2028.

Funding Requirements

We seek funding to cover a 2026 setup with $99,000 capex, Year‑1 EBITDA of −$149,000, profitability by Year‑3 with EBITDA $278,000, projected 2030 EBITDA of $1,350,000, a minimum cash buffer of $629,000 expected Jan‑2028, and overall project returns of IRR 0.04 and ROE 2.04.